1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Chile Pharmaceuticals and Healthcare Report Q3 2016

Chile Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 94 pages

Includes 3 FREE quarterly updates

BMI View: Chile's government will continue to increase its investment in healthcare and play anincreasingly important role in providing greater healthcare coverage to local citizens. This will offerconsiderable commercial opportunities for pharmaceutical companies and healthcare providers. Genericdrugmakers in particular will be able to capitalise on these opportunities as the government promotes its'Popular Pharmacy' program in a bid to offer essential medicines at very low prices.Headline Expenditure ProjectionsPharmaceuticals: From CLP2.2trn (USD3.3bn) in 2015 to CLP2.4trn (USD3.5bn) in 2016; +8.7% in localcurrency terms and +5.4% in US dollar terms. Forecast revised downwards from last quarter.Healthcare: From CLP12.7trn (USD19.4bn) in 2015 to CLP14.0trn (USD20.7bn) in 2016; +10.1% rise inlocal currency terms and +6.7% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Chile Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Chile 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Chile 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Chile 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Chile 2014-2020) 28
Industry Risk Reward Index 29
Americas Risk/Reward Index 29
Chile Risk/Reward Index 34
Rewards 34
Risks 34
Regulatory Review 36
Intellectual Property Issues 40
Pricing Regime 43
Public Procurement 43
Table: Pharmaceutical Price Build-Up (%) 43
Reimbursement Regime 44
Market Overview 46
Healthcare Sector 46
Table: Healthcare Resources (Chile 2009-2014) 51
Table: Healthcare Personnel (Chile 2009-2014) 51
Table: Healthcare Activity (2009-2014) 52
Research And Development 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 61
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 62
Company Profile 64
Corporación Farmaceutica Recalcine (CFR) 64
GlaxoSmithKline 67
Laboratorios Andrómaco 69
Laboratorios Chile (LabChile) 72
Merck and Co 75
Novartis 77
Pfizer 79
Sanofi 81
Demographic Forecast 83
Table: Population Headline Indicators (Chile 1990-2025) 84
Table: Key Population Ratios (Chile 1990-2025) 84
Table: Urban/Rural Population and Life Expectancy (Chile 1990-2025) 85
Table: Population By Age Group (Chile 1990-2025) 85
Table: Population By Age Group % (Chile 1990-2025) 86
Glossary 88
Methodology 90
Pharmaceutical Expenditure Forecast Model 90
Healthcare Expenditure Forecast Model 90
Notes On Methodology 91
Risk/Reward Index Methodology 92
Index Overview 93
Table: Pharmaceutical Risk/Reward Index Indicators 93
Indicator Weightings 94

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.